ArticleEpilepsy & behavior reports2026
Postictal electroencephalographic suppression in generalized tonic-clonic seizures: clinical correlates and predictive factors from a cross-sectional observational study.
Article in Epilepsy & behavior reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Object: This study aimed to identify clinical and seizure-related factors associated with the occurrence and duration of PGES in patients with GTCs. Method: A cross-sectional observational study was conducted on 142 patients admitted to a long-term video-EEG monitoring unit between March 2023 and 2024. Demographic, clinical, and electrographic data were extracted retrospectively. PGES was defined as generalized EEG suppression <10 µV within 30 s post-seizure. Statistical analyses included univariate comparisons and multivariate logistic regression to identify independent predictors. Result: PGES was observed in 71.1% of patients. Gradual termination of the clonic phase was the strongest independent predictor of PGES (OR = 2.32, 95% CI: 1.02-5.89, p = 0.045). Patients with PGES had significantly higher body mass index (BMI) and longer seizure durations. Focal to bilateral tonic-clonic seizures were significantly associated with prolonged PGES (>30 s). No significant differences were found in heart rate variability or postictal paresis. Conclusion: PGES is a frequent postictal phenomenon in patients with GTCs and is associated with specific seizure dynamics and systemic factors. Gradual clonic phase termination, longer seizure duration, and elevated BMI may serve as clinical markers for PGES. These findings highlight the importance of individualized postictal monitoring and may contribute to improved SUDEP risk stratification and targeted care strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.